|
|
Gene Vaccines7 c' a. \* ~) h B2 b7 ]
Thalhamer, Josef; Weiss, Richard; Scheiblhofer, Sandra (Eds.)
" N5 [5 b/ t1 f) J) v1 f6 R( }1st Edition., 2012, XI, 330 p. 49 illus., 41 in color.
& Z) k" z+ O. o. b5 ? m2 a: w g( m G- P! f3 m8 [* ?3 n
Hardcover, ISBN 978-3-7091-0438-5
7 P$ ]) n% X0 C6 a5 S1 W+ lOnline orders shipping within 2-3 days ^* _9 W1 Q6 D2 w+ `
149,95
1 E( f# j, n; k: E" o* t, c7 o" n5 ]2 d& z
目录4 N& H' Q1 ~0 [8 [
Preface.- 1 General mechanisms of gene vaccines.- 2 Strategies to Improve DNA Vaccine Potency: HPV-associated Cervical Cancer as a Model System.- 3 Immune-activating mechanisms of replicase-based DNA and RNA vaccines and their role in immune-apoptosis.- 4 Cytokine genes as molecular adjuvants for DNA vaccines.- 5 Pharmaceutical non-viral formulations for gene vaccines.- 6 Rational design of formulated DNA vaccines: the DermaVir approach.- 7 In vivo electroporation.- 8 Electroporation-based Trigrid™ delivery system (TDS) for DNA vaccine administration.- 9 Prime Boost Regimens for Enhancing Immunity: Magnitude, Quality of Mucosal and Systemic Gene Vaccines.- 10 Intranodal genetic immunization.- 11 Immunotherapy of cancer with RNA vaccines.- 12 DNA and RNA vaccines for prophylactic and therapeutic treatment of type I allergy.- 13 Approved veterinary vaccines – paving the way to products for human use.- 14 Current status of regulations for DNA vaccines.- 15 State of the art production of antibiotic resistance-free plasmid DNA.- 16 Industrial Manufacturing of Plasmid-DNA Products for Gene Vaccination and Therapy.
2 p/ p3 y* F; G4 c
/ o+ I* p3 G( m+ v$ p0 S& x下载地址:- r K$ R, ]* k& e: U" F+ A6 ^* Z
$ x. {* H- p1 t; x* i
/ n! v+ e' Q3 w$ A# n# } |
|